| NICOX SA INH. EO 0,01 |
| Frankreich |
| Gesundheit |
| FR0013018124 / A143G8 |
| NXOA (Frankfurt) |
| FRA:NXOA, ETR:NXOA, NXOA:GR |
| - |
| https://www.nicox.com/ |
|
Nicox SA is an ophthalmology company focused on developing and commercializing treatments that support vision care and ocular health. The company’s portfolio spans prescription therapies, diagnostic tools, and eye-care products designed for conditi..
>Volltext.. |
| 32.52 Mio. EUR |
| 28.78 Mio. EUR |
| 17.29 Mio. EUR |
| 2.59 Mio. EUR |
| -2.49 Mio. EUR |
| -0.05 EUR |
| 0.42 Mio. EUR |
| 4.28 Mio. EUR |
| - |
| 1.7 |
| 113.41% |
| 89.22% |
| - |
| - |
| - |
| - |
| NICOX |
| 29.09.26 |
|